NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM534336 Query DataSets for GSM534336
Status Public on Apr 20, 2010
Title RA-4 passage 1 vs. passage 3 b cancer array
Sample type RNA
 
Channel 1
Source name Rheumatoid arthritis synovial fibroblasts from Patient #4 (RA-4)
Organism Homo sapiens
Characteristics tissue: Rheumatoid arthritis synovial fibroblasts from Patient #4 (RA-4)
passage: passage 1
Treatment protocol Culture conditions were kept constant during the experiments.
Growth protocol Synovial tissues were obtained from synovial biopsies of RA patients undergoing joint surgery. Following enzymatic digestion, fibroblasts were seeded in culture flasks (= passage 0) and grown in DMEM containing 10% heat inactivated fetal calf serum and cultured at 37°C in 10% CO2. At 85-95% confluency, cells were passaged 1:2 and a part of the cells was harvested and total RNA was extracted and stored at -70°C.
Extracted molecule total RNA
Extraction protocol Total cellular RNA was extracted using the RNeasy spin column purification kit. To remove contaminating genomic DNA, total RNA was treated with DNase I (0.2 U/µl for 40 minutes at 37°C. RNA concentrations were measured, adjusted to 200 ng/µl and stored at -70°C.
Label 32P
Label protocol RAP-PCR of total cellular RNA was performed using 250 ng RNA. First strand synthesis was carried out using MuLV reverse transcriptase (Promega) and 2 µM first strand arbitary primer. Second strand synthesis was performed using AmpliTaq Stoffel Fragment 2.8 µl [32P]dATP (3,000 Ci/mmol, 10 mCi/ml), and 4 µM arbitrary second primer. The reaction was cycled through 30 low stringency cycles 94°C, 35°C, 72°C). Primer combination: OPN23 (5'- CAG GGG CAC C-3') and OPN21 (5'-ACC AGG GGC A-3').
 
Channel 2
Source name Rheumatoid arthritis synovial fibroblasts from Patient #4 (RA-4)
Organism Homo sapiens
Characteristics passage: passage 3
tissue: Rheumatoid arthritis synovial fibroblasts from Patient #4 (RA-4)
Growth protocol Synovial tissues were obtained from synovial biopsies of RA patients undergoing joint surgery. Following enzymatic digestion, fibroblasts were seeded in culture flasks (= passage 0) and grown in DMEM containing 10% heat inactivated fetal calf serum and cultured at 37°C in 10% CO2. At 85-95% confluency, cells were passaged 1:2 and a part of the cells was harvested and total RNA was extracted and stored at -70°C.
Extracted molecule total RNA
Extraction protocol Total cellular RNA was extracted using the RNeasy spin column purification kit. To remove contaminating genomic DNA, total RNA was treated with DNase I (0.2 U/µl for 40 minutes at 37°C. RNA concentrations were measured, adjusted to 200 ng/µl and stored at -70°C.
Label 32P
Label protocol RAP-PCR of total cellular RNA was performed using 250 ng RNA. First strand synthesis was carried out using MuLV reverse transcriptase (Promega) and 2 µM first strand arbitary primer. Second strand synthesis was performed using AmpliTaq Stoffel Fragment 2.8 µl [32P]dATP (3,000 Ci/mmol, 10 mCi/ml), and 4 µM arbitrary second primer. The reaction was cycled through 30 low stringency cycles 94°C, 35°C, 72°C). Primer combination: OPN23 (5'- CAG GGG CAC C-3') and OPN21 (5'-ACC AGG GGC A-3').
 
 
Hybridization protocol The PCR products were purified from unincorporated nucleotides and small cDNA fragments by column chromatography. The filters were prehybridized in prewarmed hybridization solution with 100 µg/ml fragmented denatured salmon sperm DNA. The labeled cDNA probe was denatured and 1 µg/µl sheared human genomic DNA was added with an equal volume of neutralizing solution (1M NaH2PO4, pH 7.0). The mixture was added to the filters and hybridized over night.
Scan protocol The filters were exposed to a Phosphor-Imager-Screen for 3-5 days depending on the intensity of radiation. Data analysis was performed using the Ambis software.
Description Array comparison evaluation using BD AtlasImageTM 2.7 Software providing data of differentially regulated genes (equally expressed genes are not provided by the software)
Data processing Evaluation was performed using the AtlasImageTM 2.7 software, developed specifically for analysis of the AtlasTM cDNA Expression Arrays. Background and signal intensity was normalized. The default signal threshold was kept constant for all analyses. After background correction, the median signal intensity for all spots on an array were used to calculate the correction coefficient (global normalization). Comparison of the arrays was performed using the “Compare two arrays” setting and resulting .txt-files were saved as .xls-files. Genes spotted on both arrays were evaluated on the GLP139 array only.
*********Only differentially expressed genes are reported in the Sample data tables. Complete data tables were requested and reported to be unavailable by the submitter.*********
 
Submission date Apr 19, 2010
Last update date Apr 19, 2010
Contact name Elena Neumann
E-mail(s) e.neumann@kerckhoff-klinik.de
Phone +4960329962801
Fax +4960329962809
Organization name Justus-Liebig-Universität Gießen, Kerckhoff-Klinik
Department Internal Medicine and Rheumatolgy
Lab Rheumatology Research
Street address Benekestr. 2-8
City Bad Nauheim
ZIP/Postal code 61231
Country Germany
 
Platform ID GPL131
Series (1)
GSE21385 Culture effects on rheumatoid arthrits synovial fibroblasts

Data table header descriptions
ID_REF
Intensity_1 Raw signal intensity Ch1 (Passage 1, reference)
Background_1 Background signal intensity Ch1 (Passage 1, reference)
Adj.Intensity_1 Normalized signal intensity Ch1 (Passage 1, reference)
Intensity_2 Raw signal intensity Ch2 (Passage n, test)
Background_2 Background signal intensity Ch2 (Passage n, test)
Adj.Intensity_2 Normalized signal intensity Ch2 (Passage n, test)
VALUE normalized signal intensity ratio passage n/passage 1

Data table
ID_REF Intensity_1 Background_1 Adj.Intensity_1 Intensity_2 Background_2 Adj.Intensity_2 VALUE
357 29 24 5 56 7 50.715 10.143
CA333 37 24 13 165 7 163.53 12.57923077
S106 33 24 9 279 7 281.52 31.28
C317 41 24 17 154 7 152.145 8.949705882
210 37 24 13 83 7 78.66 6.050769231
C206 150 24 126 13 7 6.21 0.049285714
CA241 77 24 53 9 7 2.07 0.039056604
CA441 8021 24 7997 2485 7 2564.73 0.320711517
C5 30 24 6 77 7 72.45 12.075

Total number of rows: 9


Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap